The settlement with Howmedica Osteonics Corporation, that does business as Stryker Orthopaedics, resolves the claims of an estimated 3,000 people who were implanted with Stryker Rejuvenate and ABG II Modular hip stems. Over 2,100 of those plaintiffs are from New Jersey with a further 1,500 national claims. The settlement will pay a base award of $300,000 per failed implant, with additional compensation available to people who suffered complications during revision surgery, which is surgery done to remove the implant.
On July 3, 2012, Stryker voluntarily recalled the hip implants, and since then the number of personal injury lawsuits has climbed steadily. The defective implants can deteriorate, allegedly producing metal debris and metal ions leading to such symptoms as pain, swelling and tissue death, a complication known as metallosis. The Stryker hip implant recall made mention of a potential risk of "fretting and/or corrosion" of the metal components of the implants.
READ MORE Stryker Rejuvenate LEGAL NEWS
The terms of the settlement, including a timeline that requires claimants to register by December 14, will see the first payouts in the summer of 2015.
Eligible claimants must be US citizens or residents and must have had both surgeries, the first to implant and the second to remove the device. The surgical procedures must have been done at a hospital in the US or a US military hospital. Additionally, the revision surgery had to occur before the November 3, 2014, the date of the settlement.